Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Debnath

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2013
Rational design of HIV-1 entry inhibitorsAsim K Debnath
Journal of Clinical Orthopaedics and Trauma|August 18, 2021
Lumbar spondylolysis - Current concepts reviewUjjwal K Debnath
Journal of Medicinal Chemistry|February 2, 1999
Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysisA K Debnath
Bollettino Dell'Ospedale Di Varese|September 1, 1993
[Not Available]P K Debnath
Expert Opinion on Investigational Drugs|April 26, 2006
Progress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1Asim K Debnath
Current Opinion in Investigational Drugs (London, England : 2000)|February 28, 2006
Prospects and strategies for the discovery and development of small-molecule inhibitors of six-helix bundle formation in class 1 viral fusion proteinsAsim K Debnath
Mini Reviews in Medicinal Chemistry|October 9, 2002
Quantitative structure-activity relationship (QSAR) paradigm--Hansch era to new millenniumA K Debnath
Indian Journal of Orthopaedics|September 21, 2020
Mesenchymal Stem Cell Therapy in Chondral Defects of Knee: Current Concept ReviewUjjwal K Debnath
Journal of Chemical Information and Computer Sciences|August 6, 1998
Comparative molecular field analysis (CoMFA) of a series of symmetrical bis-benzamide cyclic urea derivatives as HIV-1 protease inhibitorsA K Debnath
Chemical Research in Toxicology|May 1, 1993
The importance of hydrophobicity in the mutagenicity of methanesulfonic acid esters with Salmonella typhimurium TA100A K Debnath, C Hansch
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2013
Rational design of HIV-1 entry inhibitorsAsim K Debnath
Journal of Clinical Orthopaedics and Trauma|August 18, 2021
Lumbar spondylolysis - Current concepts reviewUjjwal K Debnath
Journal of Medicinal Chemistry|February 2, 1999
Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysisA K Debnath
Bollettino Dell'Ospedale Di Varese|September 1, 1993
[Not Available]P K Debnath
Expert Opinion on Investigational Drugs|April 26, 2006
Progress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1Asim K Debnath
Current Opinion in Investigational Drugs (London, England : 2000)|February 28, 2006
Prospects and strategies for the discovery and development of small-molecule inhibitors of six-helix bundle formation in class 1 viral fusion proteinsAsim K Debnath
Mini Reviews in Medicinal Chemistry|October 9, 2002
Quantitative structure-activity relationship (QSAR) paradigm--Hansch era to new millenniumA K Debnath
Indian Journal of Orthopaedics|September 21, 2020
Mesenchymal Stem Cell Therapy in Chondral Defects of Knee: Current Concept ReviewUjjwal K Debnath
Journal of Chemical Information and Computer Sciences|August 6, 1998
Comparative molecular field analysis (CoMFA) of a series of symmetrical bis-benzamide cyclic urea derivatives as HIV-1 protease inhibitorsA K Debnath
Chemical Research in Toxicology|May 1, 1993
The importance of hydrophobicity in the mutagenicity of methanesulfonic acid esters with Salmonella typhimurium TA100A K Debnath, C Hansch
Pageof 24